China Resources Double-Crane Pharmaceutical Co.,Ltd. (SHA:600062)

Market Cap	19.89B
Revenue (ttm)	10.95B
Net Income (ttm)	1.58B
Shares Out	1.03B
EPS (ttm)	1.53
PE Ratio	12.58
Forward PE	11.30
Dividend	0.47 (2.46%)
Ex-Dividend Date	Oct 28, 2025

Volume	9,046,763
Average Volume	8,120,509
Open	19.06
Previous Close	19.13
Day's Range	19.06 - 19.32
52-Week Range	17.34 - 22.62
Beta	-0.01
RSI	54.55
Earnings Date	Oct 25, 2025

About SHA:600062

China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a pharmaceutical company in the People’s Republic of China. The company offers pharmaceutical products for blood pressure, blood sugar, injection, lipid-lowering, pediatrics, nephrology, API, pharmaceutical, psychiatry/neurology, anticoagulation, oncology, women's health, anesthesia, and analgesia. The company was founded in 1939 and is headquartered in Beijing, the People’s Republic of China. China Resources Double-Crane Pharmaceutical Co.,Ltd. operates as a subsidiary of Beijing...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1939
• Employees: 13,414
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600062

Financial Performance

In 2024, SHA:600062's revenue was 11.21 billion, a decrease of -0.87% compared to the previous year's 11.31 billion. Earnings were 1.63 billion, a decrease of -2.55%.